Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:5
Drug Approvals
Brimonidine Tartrate and Timolol Maleate Eye Drops
- Product Name
- 溴莫尼定噻吗洛尔滴眼液
- Approval Number
- 国药准字H20243928
- Approval Date
- Jun 4, 2024
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20243749
- Approval Date
- May 21, 2024
NMPA
Brimonidine Tartrate Eye Drops
- Product Name
- 酒石酸溴莫尼定滴眼液
- Approval Number
- 国药准字H20243748
- Approval Date
- May 21, 2024
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20243437
- Approval Date
- Apr 7, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20234557
- Approval Date
- Nov 28, 2023
NMPA
Clinical Trials
No trials found
News
No news found